Vancomycin



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 30.9%
Staphylococcal Infection 10.4%
Cellulitis 9.1%
Osteomyelitis 8.0%
Pneumonia 6.7%
Infection 5.7%
Endocarditis 3.7%
Sepsis 2.8%
Staphylococcal Bacteraemia 2.8%
Drug Use For Unknown Indication 2.5%
Device Related Infection 2.3%
Pyrexia 2.2%
Pain 2.0%
Prophylaxis 1.9%
Febrile Neutropenia 1.7%
Antibiotic Prophylaxis 1.5%
Bacterial Infection 1.5%
Wound Infection 1.5%
Anaesthesia 1.3%
Evidence Based Treatment 1.3%
Renal Failure Acute 15.6%
Rash 10.1%
Drug Hypersensitivity 6.8%
Urticaria 5.9%
Red Man Syndrome 5.7%
Thrombocytopenia 5.5%
Blood Creatinine Increased 4.9%
Linear Iga Disease 4.5%
Pruritus 4.5%
Renal Tubular Necrosis 4.4%
Nephropathy Toxic 4.3%
Pyrexia 3.8%
Neutropenia 3.5%
Toxic Epidermal Necrolysis 3.5%
White Blood Cell Count Decreased 3.3%
Tubulointerstitial Nephritis 3.1%
Rash Erythematous 2.8%
Vomiting 2.8%
Hypotension 2.6%
Renal Tubular Disorder 2.3%
Secondary
Product Used For Unknown Indication 24.8%
Drug Use For Unknown Indication 15.4%
Sepsis 6.1%
Infection 6.1%
Staphylococcal Infection 4.9%
Pneumonia 4.9%
Hypertension 4.7%
Prophylaxis 3.8%
Pyrexia 3.7%
Device Related Infection 3.0%
Endocarditis 2.9%
Acute Myeloid Leukaemia 2.7%
Osteomyelitis 2.6%
Pain 2.5%
Bacteraemia 2.4%
Cataract Operation 2.2%
Acute Lymphocytic Leukaemia 1.9%
Antibiotic Therapy 1.9%
Cellulitis 1.8%
Meningitis 1.7%
Renal Failure Acute 13.7%
Toxic Epidermal Necrolysis 11.7%
Drug Rash With Eosinophilia And Systemic Symptoms 9.4%
Thrombocytopenia 7.2%
Pyrexia 6.2%
Toxic Skin Eruption 5.6%
Renal Failure 4.9%
Tubulointerstitial Nephritis 4.6%
Stevens-johnson Syndrome 3.8%
Septic Shock 3.8%
Staphylococcal Infection 3.8%
Vomiting 3.5%
White Blood Cell Count Decreased 3.5%
Renal Impairment 3.1%
Rash 3.0%
Sepsis 2.6%
Toxic Anterior Segment Syndrome 2.6%
Myocardial Infarction 2.5%
Blood Creatinine Increased 2.3%
Drug Reaction With Eosinophilia And Systemic Symptoms 2.3%
Concomitant
Product Used For Unknown Indication 45.0%
Drug Use For Unknown Indication 18.7%
Prophylaxis 6.0%
Pain 3.0%
Hypertension 2.8%
Acute Myeloid Leukaemia 2.8%
Coronary Artery Bypass 2.3%
Sepsis 2.1%
Pyrexia 2.1%
Infection 2.0%
Pneumonia 1.9%
Acute Lymphocytic Leukaemia 1.9%
Infection Prophylaxis 1.5%
Multiple Myeloma 1.4%
Staphylococcal Infection 1.4%
Nausea 1.2%
Febrile Neutropenia 1.1%
Constipation 1.0%
Adverse Event 1.0%
Sedation 0.9%
Vomiting 9.1%
Sepsis 8.6%
Thrombocytopenia 7.8%
Renal Failure 6.1%
White Blood Cell Count Decreased 5.8%
Pyrexia 5.5%
Renal Failure Acute 5.5%
Injury 5.3%
Pain 5.3%
Weight Decreased 4.6%
Pneumonia 4.3%
Respiratory Failure 4.2%
Unevaluable Event 4.2%
Death 4.0%
Anxiety 3.5%
Fear 3.4%
Septic Shock 3.3%
Multi-organ Failure 3.2%
White Blood Cell Count Increased 3.1%
Urinary Tract Infection 3.1%
Interacting
Bronchopulmonary Aspergillosis 31.3%
Prophylaxis 10.4%
Aspergillosis 10.0%
Stem Cell Transplant 8.0%
Endocarditis 7.0%
Grand Mal Convulsion 4.0%
Sepsis 4.0%
Osteitis 3.0%
Postoperative Care 3.0%
Product Used For Unknown Indication 3.0%
Antiplatelet Therapy 2.0%
Candidiasis 2.0%
Diabetes Mellitus 2.0%
Drug Use For Unknown Indication 2.0%
Graft Versus Host Disease 2.0%
Premedication 2.0%
Septic Embolus 1.5%
Arthritis Infective 1.0%
Bacterial Infection 1.0%
Cardiac Disorder 1.0%
Drug Interaction 21.6%
Immunosuppressant Drug Level Decreased 19.6%
Sepsis 13.7%
Hypersensitivity 11.8%
Renal Failure Acute 9.8%
Overdose 5.9%
Mucocutaneous Candidiasis 3.9%
Hypokalaemia 2.0%
Infection 2.0%
Papule 2.0%
Proteus Infection 2.0%
Rash Erythematous 2.0%
Status Epilepticus 2.0%
Urticaria 2.0%